logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/03/2026
Pfizer: The top-line results of the Phase II clinical trial of the new generation CDK4 inhibitor palbociclib as a second-line treatment for metastatic breast cancer are positive.
Latest
1 m ago
Quantum Network Company aligns its strategy with the national cybersecurity framework of the Trump administration, aiming to pursue acquisitions in the fields of quantum and network defense.
3 m ago
The main banking index in Turkey rose by 3.3%, while the main Istanbul Stock Exchange National 100 Index in Turkey increased by 1.56%.
4 m ago
Xiangteng new materials: Several shareholders have reduced their holdings by 2.93%.
5 m ago
Nasdaq: the abbreviation of the securities is proposed to be changed to "Pentu Technology"
5 m ago
Hailian Jinhui: Intends to invest 10.4 million yuan to subscribe for 16.64% stake in industrial investment fund.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.